Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Novo Nordisk Canada announced that Health Canada has accepted for review, under the Priority Review policy, its supplemental ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

In a significant medical breakthrough, researchers from King’s College London have found that semaglutide, a drug commonly ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.